Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, TRI

UAB Selects XpertDox Clinical Trial Recruitment Platform To Accelerate Medical Research


BIRMINGHAM, Ala., July 31, 2018 /PRNewswire/ -- XpertDox, a data analytics firm focused on improving healthcare outcomes for patients with serious and rare diseases, today announced that the University of Alabama at Birmingham (UAB), one of the largest academic medical centers in the United States, has selected the Company's XpertTrialTM Platform to improve clinical trial enrollment timelines and accelerate patient recruitment for medical research (Link). The goal of this collaboration is to promote access to promising clinical studies while improving outcomes for patients and clinicians.

"We are proud to partner with UAB to improve patient enrollment across the University's vibrant network of clinical trials," said Sameer Ather, M.D., Ph.D., CEO and co-founder of XpertDox.  "UAB is a recognized leader in medical research and an ideal partner for XpertDox and the XpertTrial Platform. The XpertTrial Platform is unique in its utilization of big data to address the challenges of clinical trial matching, integrating the most advanced technology into the highest quality options available for patients."

XpertTrial is a natural language processing search engine that matches 50,000 keywords to a list of active clinical trials across all diseases, procedures, symptoms, and specialties.  The functionality and computing power used by XpertTrial represents significant improvement over previous clinical enrollment products.

Dr. Ather continued, "Patients, particularly those with serious and rare diseases, want to learn about treatment options including the latest clinical studies but, historically, information has been decentralized and scarce. The XpertTrial Platform has been designed specifically to accelerate access to information, providing patients with the detailed information necessary to make informed decisions.  This collaboration will allow patients to search for information about the hundreds of ongoing trials at UAB, identifying opportunities and improving access to the latest research. We believe that XpertTrial has the potential to change the paradigm of clinical trial enrollment at UAB and across the United States."

About XpertDox

A business-to-business (B2B) data analytics firm, XpertDox is dedicated to improving healthcare outcomes to patients with rare and serious conditions. The company partners with healthcare companies, organizations, and institutions, finding doctors for patients, while facilitating enrollment for life-saving clinical trials worldwide. Leveraging multiple data sets, XpertDox uses a proprietary algorithm to find patients, doctors and key opinion leaders in over 6,000 diseases. XpertDox is headquartered in Birmingham, Alabama. For additional information visit www.xpertdox.com.

Contact:
Sameer Ather, XpertDox
[email protected], 205-259-6045
2052596045
[email protected]

Photo(s):
https://www.prlog.org/12721596

Press release distributed by PRLog

 

SOURCE XpertDox


These press releases may also interest you

25 avr 2024
AZZ Inc. , the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced the pricing of its underwritten public offering of 4,000,000 shares of common stock at a public offering price per share of $70.00, for...

25 avr 2024
CarLotz, Inc.  Accused of Misleading Investors On March 29, 2024, the defendants' motion to dismiss in the pending securities class...

25 avr 2024
TSX VENTURE COMPANIES BULLETIN V2024-1200 LEONOVUS INC. ("LTV.WT")BULLETIN TYPE:  Warrant Expiry-DelistBULLETIN DATE:  April 25, 2024TSX Venture Tier 2 Company Effective at the opening, May 2, 2024, the Share Purchase Warrants of the Company will...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
Dominion Lending Centres Inc. ("DLCG" or the "Corporation") is pleased to announce that it has completed a sale of its 52% interest in Cape Communications International Inc. ("Impact") for aggregate cash proceeds of $3.71 million (the "Purchase...

25 avr 2024
Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) ("the Company" or "Orbia") today released unaudited results for the first quarter of 2024. Orbia's first quarter performance reflects the continued weakness in the market environment,...



News published on and distributed by: